Share Results

Share the formulary results with your colleague. Fill in the required fields below and click "Submit." Please note: formulary results are intended for professionals only. Your e-mail address and that of your recipient will be used for transmission only and will not be stored or used for any other purpose.
* = Required Field
*Your Name:


*Your E-mail:


*Recipient Name:


*Recipient E-mail:

Thank You

Thank you for sharing formulary results for
ACCOLATE^® Tablets (eformularyDrug.chemicalName). The e-mail has been sent. To return to the Formulary Finder page, close the
pop-up window.

Choose Plans to View Results

Choose up to eight (8) plans and click Submit to view results.

Only up to 8 plans may be selected at a time.

Compare Formulary Status

Choose up to two (2) medications and click Submit to compare.

Up to 2 medications can be selected at a time.

AZ Gateway AZ Connect

Call Me Now

Sorry, there are no Personal Account Specialists currently available.

If you would like information regarding products from AstraZeneca, please call 1-888-692-9737, during our normal business hours Monday through Friday, 8:30 am to 8:30 pm ET, excluding holidays.

AZ Gateway AZ Connect

AZ TouchPoints News

: The AZ TouchPoints Web site gives you direct access to AstraZeneca services and support. Here, you can easily find online sample ordering, formulary information, and patient education materials for select AstraZeneca medicines. Read more

AstraZeneca Professional Sites

To learn more about AstraZeneca medicines, visit the AZ corporate site for a complete list of professional Web sites.
Go to Web site directory

AstraZeneca Medical Affairs

Visit the AstraZeneca medical affairs Web site to get answers to questions about AZ products and medicines.
Go to AZ US Medical Information

Home

AZ Services

AZ TouchPoints

Formulary Finder

Formulary News

As of July 1, 2009, Prevacid^® (lansoprazole) was removed from the Caremark National Preferred Drug List. NEXIUM^® (esomeprazole magnesium) remains a Preferred brand.¹
Reference: 1. Caremark Primary Preferred and Performance Drug Lists as of July 1, 2009.

Formulary Search

Step 1: Select Brand

Step 2: Select State	Step 4: Select Plans to View Formulary Results

Step 3: Select Plan Type	Step 5 (optional): Compare Formulary Status

Prescribing Information

Plan Name

Please select a state, plan type, and then select a specific plan to review results.

Source: Fingertip Formulary^® as of 01/17/10.

Tier 1 = generic; Tier 2 = preferred; Tier 3-6 = non-preferred; N/A = not available; NC = not covered; PA = prior authorization; QL = quantity limits; ST = step therapy; OR = other restrictions.

AstraZeneca does not endorse any individual plan or plans.

The list of medications under the "Compare Formulary Status" menu is provided by Fingertip Formulary^® and does not imply comparable efficacy, safety, or FDA-approved indications. All registered trademarks are registered to their respective companies and are not licensed or manufactured by AstraZeneca.

Fingertip Formulary is a registered trademark of Fingertip Formulary, LLC.

Formulary Finder

Brand:

State:

Plan Type:

Plan Name

Please select a state, plan type, and then select a specific plan to review results.

Source: Fingertip Formulary^® as of 01/17/10.

Tier 1 = generic; Tier 2 = preferred; Tier 3-6 = non-preferred; N/A = not available; NC = not covered; PA = prior authorization; QL = quantity limits; ST = step therapy; OR = other restrictions.

AstraZeneca does not endorse any individual plan or plans.

Fingertip Formulary is a registered trademark of Fingertip Formulary, LLC.

Approved Uses

Healing of Erosive Esophagitis (EE)

NEXIUM 40 mg and NEXIUM 20 mg are indicated for short-term treatment (4 to 8 weeks) in healing and symptomatic resolution of diagnostically confirmed EE.

Maintenance of Healing of EE

NEXIUM 20 mg is indicated to maintain symptom resolution and healing of EE. Controlled studies did not extend beyond 6 months.

Symptomatic GERD

NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated with GERD.

Pediatric Use

NEXIUM is indicated for the short-term treatment (up to 8 weeks) of GERD (symptomatic GERD and healing of EE) in patients 1 to 17 years of age. Pediatric use is supported by extrapolation of results from studies that supported the approval for NEXIUM for adults and safety and pharmacokinetic studies performed in pediatric and adolescent patients.

Effectiveness has not been demonstrated in patients less than 1 year of age. Safety and effectiveness for other pediatric uses have not been established.

Important Safety Information

NEXIUM^® (esomeprazole magnesium) is contraindicated in patients with known hypersensitivity to any component of the formulation or to substituted benzimidazoles
In adult patients, the most frequently reported adverse events (AEs) with NEXIUM include headache, diarrhea, and abdominal pain
In pediatric patients 1 to 17 years of age, the most frequently reported AEs with NEXIUM include headache, diarrhea, abdominal pain, nausea, and somnolence
Symptomatic response to therapy does not preclude the presence of gastric malignancy
Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with omeprazole, of which NEXIUM is an enantiomer
As with all PPIs, patients treated concomitantly with warfarin may need to be monitored for increases in INR and prothrombin time. Like other PPIs, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, ketoconazole, iron salts, and digoxin)
Concomitant use of NEXIUM and atazanavir or nelfinavir is not recommended because the plasma concentrations and therapeutic effects of those antiretroviral drugs may be reduced
NEXIUM may increase the plasma levels of saquinavir. Dose reduction of saquinavir should be considered
NEXIUM should be used only for the conditions, dosages, and durations specified in the Prescribing Information. Dosing for adults and pediatrics is provided in the Prescribing Information

NEXIUM

Please see the full Prescribing Information available at the Web site for NEXIUM.

Please click here for the full Prescribing Information pdf (PDF – 303 KB) for NEXIUM.

Log In	Close
* = Required field
* E-mail Address

* Password
Remember my e-mail address
Forgot Password?
Not Registered?

Forgot Your Password?	Close
To receive an e-mail with your password, please enter the e-mail address you provided for this account.
* = Required field
* E-mail Address
Return to Log In

* = Required field
Find your Personal Account Specialist for NEXIUM® (esomeprazole magnesium), who can answer questions and provide information. Fill out the fields below to get started. Review full Prescribing information for NEXIUM
* Enter Zip Code:
* Your First Name:	* Your Last Name:

Share Results

Thank You

Choose Plans to View Results

Compare Formulary Status

Log In

Not Registered?

Forgot Your Password?

Log In

Thank you

Find My Representative

Call Me Now

Sorry, there are no Personal Account Specialists currently available.

AZ TouchPoints News

AstraZeneca Professional Sites

AstraZeneca Medical Affairs

Formulary Finder

Formulary News

Formulary Search

Plan Name

Formulary Finder

Brand:

State:

Plan Type:

Plan Name

Forgot Your
Password?